Halozyme Therapeutics (HALO) Q3 2026 Earnings

11AugConfirmed
Q4 2025
Q1 2026
Q2 2026
Next
-0.24
0.57
1.39
2.2

Details

Expected EPS
1.803772
Actual EPS
N/A
Surprise EPS
-1.8
Surprise Percent
+100%

Description

Halozyme Therapeutics (HALO) will report earnings of for Q3 2026 on August 11, 2026.

0 Comments

Share your thoughts